เชิงอรรถและอ้างอิง ของ ยาแก้ซึมเศร้า

  1. ↑ "antidepressant", ศัพท์บัญญัติอังกฤษ-ไทย, ไทย-อังกฤษ ฉบับราชบัณฑิตยสถาน (คอมพิวเตอร์) รุ่น ๑.๑ ฉบับ ๒๕๔๕, ๑. ยาแก้ซึมเศร้า ๒. -แก้ซึมเศร้า
  2. 1 2 3 4 5 Linde, K; Kriston, L; Rücker, G; Jamila, S; Schumann, I; Meissner, K; Sigterman, K; Schneider, A (2015-02). "Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis". Ann Fam Med. 13 (1): 69–79. doi:10.1370/afm.1687. PMC 4291268. PMID 25583895. In network meta-analysis, tricyclic and tetracyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), a serotonin-noradrenaline reuptake inhibitor (SNRI; venlafaxine), a low-dose serotonin antagonist and reuptake inhibitor (SARI; trazodone) and hypericum extracts were found to be significantly superior to placebo, with estimated odds ratios between 1.69 and 2.03. There were no statistically significant differences between these drug classes. Reversible inhibitors of monoaminoxidase A (rMAO-As) and hypericum extracts were associated with significantly fewer dropouts because of adverse effects compared with TCAs, SSRIs, the SNRI, a noradrenaline reuptake inhibitor (NRI), and noradrenergic and specific serotonergic antidepressant agents (NaSSAs). ... TCAs and SSRIs have the most solid evidence base. Further agents (hypericum, rMAO-As, SNRI, NRI, NaSSAs, SARI) showed some positive results, but limitations of the currently available evidence makes a clear recommendation on their place in clinical practice difficult. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Linde, K; Berner, MM; Kriston, L (2008). "St John's wort for major depression". Cochrane Database Syst Rev (4): CD000448. doi:10.1002/14651858.CD000448.pub3. PMID 18843608.CS1 maint: Uses authors parameter (link)
  4. ↑ Hamilton, M (1960). "A rating scale for depression". J. Neurol. Neurosurg. Psychiatr. 23: 56–62. doi:10.1136/jnnp.23.1.56. PMC 495331. PMID 14399272.
  5. ↑ แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป, "ALGORITHM 1 ASSESSMENT OF MAJOR DEPRESSIVE DISORDER", หน้า 15
  6. ↑ "Depression in adults: The treatment and management of depression in adults". NICE guidelines [CG90]. National Institute for Health and Care Excellence (UK). 2009-10. สืบค้นเมื่อ 2015-09-23. Check date values in: |date= (help)
  7. ↑ "PsychiatryOnline | APA Practice Guidelines | Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition".
  8. ↑ แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป, "Summary of Recommendations", หน้า 13-14
  9. ↑ แนวทางการจัดการโรคซึมเศร้าสำหรับแพทย์เวชปฏิบัติทั่วไป Appendix 11, หน้า 62-63
  10. ↑ Kirsch, I; Moore, TJ; Scoboria, A; Nicholls, SS (2002). "The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration". Prevention & Treatment. 5. doi:10.1037/1522-3736.5.1.523a.CS1 maint: Uses authors parameter (link)
  11. ↑ "Study: Antidepressant barely better than placebo". USA Today. 2002-07-07. สืบค้นเมื่อ 2008-11-06.
  12. ↑ Kirsch, I; Deacon, BJ; Huedo-Medina, TB; Scoboria, A; Moore, TJ; Johnson, BT (2008). "Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration". PLoS Medicine. 5 (2): e45. doi:10.1371/journal.pmed.0050045. PMC 2253608. PMID 18303940.CS1 maint: Uses authors parameter (link)
  13. ↑ Fournier, JC; DeRubeis, RJ; Hollon, SD และคณะ (2010-01). "Antidepressant drug effects and depression severity: a patient-level meta-analysis". JAMA. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  14. ↑ Borges, S; Chen, YF; Laughren, TP; Temple, R; Patel, HD; David, PA; Mathis, M; Unger, E; Yang, P; Khin, NA (2014). "Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration". J Clin Psychiatry. 75 (3): 205–14. doi:10.4088/JCP.13r08722. PMID 24717376.CS1 maint: Uses authors parameter (link)
  15. ↑ "Depression in Adults (update)" (PDF). National Collaborating Centre for Mental Health Commissioned by the National Institute for Health and Care Excellence. www.nice.org.uk. pp. 282–292. Archived from the original (PDF) on 2013-06-12. สืบค้นเมื่อ 2013-11-20.
  16. ↑ Leucht, C; Huhn, M; Leucht, S (2012). Leucht, C, ed. "Amitriptyline versus placebo for major depressive disorder". Cochrane Database of Systematic Reviews. 12: CD009138. doi:10.1002/14651858.CD009138.pub2. PMID 23235671.CS1 maint: Uses authors parameter (link)
  17. ↑ Zhou, X; Ravindran, AV; Qin, B; Del Giovane, C; Li, Q; Bauer, M; Liu, Y; Fang, Y; da Silva, T; Zhang, Y; Fang, L; Wang, X; Xie, P (2015-04). "Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis". J Clin Psychiatry. 76 (4): e487–98. doi:10.4088/JCP.14r09204. PMID 25919841. Quetiapine and aripiprazole appear to be the most robust evidence-based options for augmentation therapy in patients with treatment-resistant depression Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  18. ↑ Walsh, BT; Seidman, SN; Sysko, R; Gould, M (2002). "Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing". JAMA. 287 (14): 1840–7. doi:10.1001/jama.287.14.1840. PMID 11939870.CS1 maint: Uses authors parameter (link)
  19. ↑ Freeman, MP; Mischoulon, D; Tedeschini, E; Goodness, T; Cohen, LS; Fava, M; Papakostas, GI (2010). "Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants". J Clin Psychiatry. 71 (6): 682–8. doi:10.4088/JCP.10r05976blu. PMID 20573327.CS1 maint: Uses authors parameter (link)
  20. ↑ Lee, K; Bacchetti, P; Sim, I (2008). Clarke, Mike, ed. "Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis". PLoS Medicine. 5 (9): e191. doi:10.1371/journal.pmed.0050191. PMC 2553819. PMID 18816163.CS1 maint: Uses authors parameter (link)
  21. ↑ Whittington, CJ; Kendall, T; Fonagy, P; Cottrell, D; Cotgrove, A; Boddington, E (2004). "Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data". The Lancet. 363 (9418): 1341–5. doi:10.1016/S0140-6736(04)16043-1. PMID 15110490.CS1 maint: Uses authors parameter (link)
  22. ↑ Ebrahim, Shanil (2015). "Meta-analyses with industry involvement are massively published and report no caveats for antidepressants". Journal of Clinical Epidemology. doi:10.1016/j.jclinepi.2015.08.021. PMID 26399904. Lay summary.
  23. ↑ Gibbons, RD; Hur, K; Brown, CH; Davis, JM; Mann, JJ (2012-06). "Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine". Archives of General Psychiatry. 69 (6): 572–9. doi:10.1001/archgenpsychiatry.2011.2044. PMC 3371295. PMID 22393205. Check date values in: |date= (help)
  24. ↑ Taylor, MJ; Freemantle, N; Geddes, JR; Bhagwagar, Z (2006). "Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis". Archives of General Psychiatry. 63 (11): 1217–23. doi:10.1001/archpsyc.63.11.1217. PMC 2211759. PMID 17088502.CS1 maint: Uses authors parameter (link)
  25. ↑ "Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study". National Institute of Mental Health. Archived from the original on 2013-03-05. สืบค้นเมื่อ 2012-11-28.
  26. ↑ Fava, M; Rush, AJ; Wisniewski, SR; Nierenberg, AA; Alpert, JE; McGrath, PJ; Thase, ME; Warden, D; Biggs, M; Luther, JF; Niederehe, G; Ritz, L; Trivedi, MH (2006). "A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report". The American Journal of Psychiatry. 163 (7): 1161–72. doi:10.1176/appi.ajp.163.7.1161. PMID 16816220.CS1 maint: Uses authors parameter (link)
  27. 1 2 Trivedi, MH; Fava, M; Wisniewski, SR; Thase, ME; Quitkin, F; Warden, D; Ritz, L; Nierenberg, AA; Lebowitz, BD; Biggs, MM; Luther, JF; Shores-Wilson, K; Rush, AJ (2006). "Medication Augmentation after the Failure of SSRIs for Depression". New England Journal of Medicine. 354 (12): 1243–52. doi:10.1056/NEJMoa052964. PMID 16554526.CS1 maint: Uses authors parameter (link)
  28. ↑ Cusin, Cristina; Yang, Huaiyu; Yeung, Albert; Fava, Maurizio (2010). "Rating scales for depression" (PDF). In Baer, L; Blais, MA. Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health (PDF)|format= requires |url= (help). New York: Springer. pp. 7–36. ISBN 9781588299666.CS1 maint: Multiple names: authors list (link) CS1 maint: Uses editors parameter (link)
  29. ↑ Trivedi, MH; Rush, AJ; Wisniewski, SR; Nierenberg, AA; Warden, D; Ritz, L; Norquist, G; Howland, RH; Lebowitz, B; McGrath, PJ; Shores-Wilson, K; Biggs, MM; Balasubramani, GK; Fava, M (2006). "Evaluation of Outcomes with Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice". American Journal of Psychiatry. 163 (1): 28–40. doi:10.1176/appi.ajp.163.1.28. PMID 16390886.CS1 maint: Uses authors parameter (link)
  30. ↑ Warden, D; Trivedi, MH; Wisniewski, SR; Davis, L; Nierenberg, AA; Gaynes, BN; Zisook, S; Hollon, SD; Balasubramani, GK; Howland, R; Fava, M; Stewart, JW; Rush, AJ (2007). "Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report". Am J Psychiatry. 164 (8): 1189–97. doi:10.1176/appi.ajp.2007.06071225. PMID 17671281.CS1 maint: Uses authors parameter (link)
  31. ↑
  32. ↑ Rush, AJ; Trivedi, MH; Wisniewski, SR; Stewart, JW; Nierenberg, AA; Thase, ME; Ritz, L; Biggs, MM; Warden, D; Luther, JF; Shores-Wilson, K; Niederehe, G; Fava, M (2006). "Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression". New England Journal of Medicine. 354 (12): 1231–42. doi:10.1056/NEJMoa052963. PMID 16554525.CS1 maint: Uses authors parameter (link)
  33. ↑ Rush, AJ; Trivedi, MH; Wisniewski, SR และคณะ (2006-11). "Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report". Am J Psychiatry. 163 (11): 1905–17. doi:10.1176/appi.ajp.163.11.1905. PMID 17074942. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  34. ↑ Warden, D; Rush, AJ; Trivedi, MH; Fava, M; Wisniewski, SR (2007). "The STAR*D Project results: A comprehensive review of findings". Current Psychiatry Reports. 9 (6): 449–59. doi:10.1007/s11920-007-0061-3. PMID 18221624.CS1 maint: Uses authors parameter (link)
  35. ↑ Baghai, TC; Möller, HJ; Rupprecht, R (2006). "Recent Progress in Pharmacological and Non-Pharmacological Treatment Options of Major Depression". Current Pharmaceutical Design. 12 (4): 503–15. doi:10.2174/138161206775474422. PMID 16472142.CS1 maint: Uses authors parameter (link)
  36. 1 2 Ruhé, HG; Huyser, J; Swinkels, JA; Schene, AH (2006). "Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder". The Journal of Clinical Psychiatry. 67 (12): 1836–55. doi:10.4088/JCP.v67n1203. PMID 17194261.CS1 maint: Uses authors parameter (link)
  37. ↑ Tranter, R; O'Donovan, C; Chandarana, P; Kennedy, S (2002). "Prevalence and outcome of partial remission in depression". Journal of Psychiatry & Neuroscience. 27 (4): 241–7. PMC 161658. PMID 12174733.CS1 maint: Uses authors parameter (link)
  38. ↑ Byrne, SE; Rothschild, AJ (1998). "Loss of Antidepressant Efficacy During Maintenance Therapy". The Journal of Clinical Psychiatry. 59 (6): 279–88. doi:10.4088/JCP.v59n0602. PMID 9671339.CS1 maint: Uses authors parameter (link)
  39. ↑ "Antidepressant Use in Persons Aged 12 and Over: United States, 2005-2008". www.cdc.gov. Products - Data Briefs - Number 76 - October 2011. Centers for Disease Control and Prevention. สืบค้นเมื่อ 2016-02-04.
  40. ↑ Mischoulon, D; Nierenberg, AA; Kizilbash, L; Rosenbaum, JF; Fava, M (2000). "Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians". Canadian Journal of Psychiatry. 45 (5): 476–81. PMID 10900529.CS1 maint: Uses authors parameter (link)
  41. ↑ Bschor, T; Baethge, C (2010). "No evidence for switching the antidepressant: Systematic review and meta-analysis of RCTs of a common therapeutic strategy". Acta Psychiatrica Scandinavica. 121 (3): 174–9. doi:10.1111/j.1600-0447.2009.01458.x. PMID 19703121.CS1 maint: Uses authors parameter (link)
  42. ↑ DeBattista, C; Lembke, A (2005). "Update on augmentation of antidepressant response in resistant depression". Current Psychiatry Reports. 7 (6): 435–40. doi:10.1007/s11920-005-0064-x. PMID 16318821.CS1 maint: Uses authors parameter (link)
  43. ↑ Lam, RW; Wan, DD; Cohen, NL; Kennedy, SH (2002). "Combining Antidepressants for Treatment-Resistant Depression". The Journal of Clinical Psychiatry. 63 (8): 685–93. doi:10.4088/JCP.v63n0805. PMID 12197448.CS1 maint: Uses authors parameter (link)
  44. ↑ Goss, AJ; Kaser, M; Costafreda, SG; Sahakian, BJ; Fu, CH (2013). "Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials". The Journal of Clinical Psychiatry. 74 (11): 1101–7. doi:10.4088/JCP.13r08560. PMID 24330897.CS1 maint: Uses authors parameter (link)
  45. ↑ Geddes, JR; Carney, SM; Davies, C; Furukawa, TA; Kupfer, DJ; Frank, E; Goodwin, GM (2003). "Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review". The Lancet. 361 (9358): 653–61. doi:10.1016/S0140-6736(03)12599-8. PMID 12606176.CS1 maint: Uses authors parameter (link)
  46. ↑ Targum, SD (2014-03). "Identification and treatment of antidepressant tachyphylaxis". Innov Clin Neurosci. 11 (3–4): 24–8. PMC 4008298. PMID 24800130. Check date values in: |date= (help)
  47. ↑ Fava, GA; Offidani, E (2011). "The mechanisms of tolerance in antidepressant action". Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35 (7): 1593–602. doi:10.1016/j.pnpbp.2010.07.026. PMID 20728491.CS1 maint: Uses authors parameter (link)
  48. ↑ Fava, GA; Park, SK; Sonino, N (2006). "Treatment of recurrent depression". Expert Review of Neurotherapeutics. 6 (11): 1735–40. doi:10.1586/14737175.6.11.1735. PMID 17144786.CS1 maint: Uses authors parameter (link)
  49. ↑ Petersen, TJ (2006). "Enhancing the efficacy of antidepressants with psychotherapy". Journal of Psychopharmacology. 20 (3 suppl): 19–28. doi:10.1177/1359786806064314. PMID 16644768.
  50. 1 2 3 4 5 6 7 8 9 10 Brunton, Laurence L.; Chabner, Bruce; Knollmann, Björn C., eds. (2011). Goodman and Gilman's The Pharmacological Basis of Therapeutics (12th ed.). New York: McGraw-Hill Professional. ISBN 978-0-07-162442-8.
  51. 1 2 3 4 5 6 7 8 9 10 11 "Side effects of antidepressant medications". UpToDate. Wolters Kluwer Health. Archived from the original on 2013-11-02. สืบค้นเมื่อ 2013-10-24.
  52. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Royal Pharmaceutical Society of Great Britain. MARTINDALE - The Complete Drug Reference. Pharmaceutical Press. Archived from the original on 2013-07-26. สืบค้นเมื่อ 2013-10-31.
  53. 1 2 3 4 5 6 7 8 9 10 11 12 Ernst E; Rand JI; Barnes J; Stevinson C (1998). "Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.)". European Journal of Clinical Pharmacology. 54 (8): 589–94. doi:10.1007/s002280050519. PMID 9860144. Collectively, the data suggest that hypericum is well tolerated, with an incidence of adverse reactions similar to that of placebo.
  54. 1 2 3 Cipriani, A; Furukawa, TA; Salanti, G; Geddes, JR; Higgins, JP; Churchill, R; Watanabe, N; Nakagawa, A; Omori, IM; McGuire, H; Tansella, M; Barbui, C (2009). "Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis". Lancet. 373 (9665): 746–58. doi:10.1016/S0140-6736(09)60046-5. PMID 19185342.CS1 maint: Uses authors parameter (link)
  55. 1 2 3 4 5 6 7 8 9 10 11 12 Taylor, D; Paton, C; Shitij, K (2012). The Maudsley prescribing guidelines in psychiatry. West Sussex: Wiley-Blackwell. ISBN 978-0-470-97948-8.
  56. 1 2 White, N; Litovitz, T; Clancy, C (2008). "Suicidal antidepressant overdoses: a comparative analysis by antidepressant type". J Med Toxicol. 4 (4): 238–50. doi:10.1007/BF03161207. PMC 3550116. PMID 19031375.CS1 maint: Uses authors parameter (link)
  57. 1 2 3 4 5 6 7 8 Rossi, S, ed. (2013). Australian Medicines Handbook (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. ISBN 978-0-9805790-9-3.
  58. ↑ Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW; van Hulst, AM; van der Mast, RC; van de Wetering, BJ (1996). "A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients". Psychopharmacology. 127 (3): 231–7. doi:10.1007/BF02246131. PMID 8912401.CS1 maint: Uses authors parameter (link)
  59. ↑ Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW (1999). "Depressed in-patients respond differently to imipramine and mirtazapine". Pharmacopsychiatry. 32 (3): 87–92. doi:10.1055/s-2007-979200. PMID 10463374.CS1 maint: Uses authors parameter (link)
  60. ↑ van Moffaert, M; de Wilde, J; Vereecken, A; Dierick, M; Evrard, JL; Wilmotte, J; Mendlewicz, J (1995-03). "Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression". Int Clin Psychopharmacol. 10 (1): 3–9. doi:10.1097/00004850-199503000-00001. PMID 7622801. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  61. ↑ Goodwin, GM (2009). "Clinical studies on the efficacy of agomelatine on depressive symptoms". CNS Drugs. 23 Suppl 2: 35–9. doi:10.2165/11318650-000000000-00000. PMID 19708724.
  62. 1 2 3 4 5 6 7 8 9 10 11 Voican, CS; Corruble, E; Naveau, S; Perlemuter, G (2014-04). "Antidepressant-induced liver injury: a review for clinicians". The American Journal of Psychiatry. 171 (4): 404–15. doi:10.1176/appi.ajp.2013.13050709. PMID 24362450. Check date values in: |date= (help)
  63. ↑ "AMOXAPINE tablet [Watson Laboratories, Inc.]". DailyMed. Watson Laboratories, Inc. 2010-08. Archived from the original on 2013-11-02. สืบค้นเมื่อ 2013-10-30. Check date values in: |date= (help)
  64. 1 2 Walker, R; Whittlesea, C, eds. (2007) [1994]. Clinical Pharmacy and Therapeutics (4th ed.). Edinburgh: Churchill Livingstone Elsevier. ISBN 978-0-7020-4293-5.
  65. 1 2 Fishback, JA; Robson, MJ; Xu, YT; Matsumoto, RR (2010). "Sigma receptors: potential targets for a new class of antidepressant drug". Pharmacol. Ther. 127 (3): 271–82. doi:10.1016/j.pharmthera.2010.04.003. PMC 3993947. PMID 20438757.CS1 maint: Uses authors parameter (link)
  66. 1 2 Kishimoto, A; Todani, A; Miura, J; Kitagaki, T; Hashimoto, K (2010). "The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report". Ann Gen Psychiatry. 9: 23. doi:10.1186/1744-859X-9-23. PMC 2881105. PMID 20492642.CS1 maint: Uses authors parameter (link)
  67. ↑ Borkowska, A; Pilaczyńska, E; Araszkiewicz, A; Rybakowski, J (2002). "[The effect of sertraline on cognitive functions in patients with obsessive-compulsive disorder]". Psychiatr. Pol. (in Polish). 36 (6 Suppl): 289–95. PMID 12647451.CS1 maint: Uses authors parameter (link) CS1 maint: Unrecognized language (link)
  68. ↑ Schmitt, JA; Ramaekers, JG; Kruizinga, MJ; van Boxtel, MP; Vuurman, EF; Riedel, WJ (2002). "Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man". J. Psychopharmacol. 16 (3): 207–14. doi:10.1177/026988110201600303. PMID 12236626.CS1 maint: Uses authors parameter (link)
  69. ↑ Joint Formulary Committee (2013). British National Formulary (BNF) (65 ed.). London, UK: Pharmaceutical Press. ISBN 978-0-85711-084-8.
  70. 1 2 "Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults" (PDF). NICE. Archived from the original (PDF) on 2012-10-21. สืบค้นเมื่อ 2013-02-20.
  71. 1 2 Kapczinski, F; Lima, MS; Souza, JS; Schmitt, R (2003). Kapczinski, Flavio FK, ed. "Antidepressants for generalized anxiety disorder". Cochrane Database Syst Rev (2): CD003592. doi:10.1002/14651858.CD003592. PMID 12804478.CS1 maint: Uses authors parameter (link)
  72. ↑ "Obsessive-compulsive disorder: Core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder" (PDF). 2005-11. Check date values in: |date= (help)
  73. ↑ Arroll, B; Elley, CR; Fishman, T; Goodyear-Smith, FA; Kenealy, T; Blashki, G; Kerse, N; Macgillivray, S (2009). Arroll, Bruce, ed. "Antidepressants versus placebo for depression in primary care". The Cochrane Database of Systematic Reviews (3): CD007954. doi:10.1002/14651858.CD007954. PMID 19588448.CS1 maint: Multiple names: authors list (link)
  74. ↑ "Medscape Log In". Archived from the original on 2013-04-13.
  75. ↑ Fineberg, NA; Brown, A; Reghunandanan, S; Pampaloni, I (2012). "Evidence-based pharmacotherapy of obsessive-compulsive disorder". The International Journal of Neuropsychopharmacology. 15 (8): 1173–91. doi:10.1017/S1461145711001829. PMID 22226028.CS1 maint: Uses authors parameter (link)
  76. ↑ "Sertraline prescribing information" (PDF). FDA. สืบค้นเมื่อ 2015-01-30.
  77. ↑ "Paroxetine prescribing information" (PDF). Apotex. สืบค้นเมื่อ 2015-01-30.
  78. 1 2 3 "Eating disorders in over 8s: management" (PDF). NICE. 2004-01. Check date values in: |date= (help)
  79. ↑ "Bupropion". MedlinePlus. 2016-15-02. สืบค้นเมื่อ 2016-10-03. Check date values in: |date= (help)
  80. 1 2 "National Guideline Clearinghouse | Practice guideline for the treatment of patients with eating disorders".
  81. ↑ Flament, MF; Bissada, H; Spettigue, W (2012-03). "Evidence-based pharmacotherapy of eating disorders". The International Journal of Neuropsychopharmacology. 15 (2): 189–207. doi:10.1017/S1461145711000381. PMID 21414249. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  82. ↑ Häuser, W; Wolfe, F; Tölle, T; Uçeyler, N; Sommer, C (2012-04). "The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis". CNS Drugs. 26 (4): 297–307. doi:10.2165/11598970-000000000-00000. PMID 22452526. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  83. ↑ doi:10.1136/ard.2007.071522
    This citation will be automatically completed in the next few minutes. You can jump the queue or expand by hand Full Article PDF (135 KB)
  84. ↑ Lunn, MP; Hughes, RA; Wiffen, PJ (2014). "Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia". Cochrane Database Syst Rev. 1: CD007115. doi:10.1002/14651858.CD007115.pub3. PMID 24385423.CS1 maint: Uses authors parameter (link)
  85. ↑ update Moore, RA; Derry, S; Aldington, D; Cole, P; Wiffen, PJ (2012). "Amitriptyline for neuropathic pain and fibromyalgia in adults". Cochrane Database Syst Rev. 12: CD008242. doi:10.1002/14651858.CD008242.pub2. PMID 23235657.CS1 maint: Uses authors parameter (link)
  86. ↑ Birmes, P; Coppin, D; Schmitt, L; Lauque, D (2003). "Serotonin syndrome: a brief review". CMAJ. 168 (11): 1439–42. PMC 155963. PMID 12771076.CS1 maint: Uses authors parameter (link)
  87. ↑ Boyer, EW; Shannon, M (2005). "The serotonin syndrome" (PDF). N. Engl. J. Med. 352 (11): 1112–20. doi:10.1056/NEJMra041867. PMID 15784664. Archived from the original (PDF) on 2013-06-18.CS1 maint: Uses authors parameter (link)
  88. ↑ Mason, PJ; Morris, VA; Balcezak, TJ (2000). "Serotonin syndrome. Presentation of 2 cases and review of the literature". Medicine. 79 (4): 201–9. doi:10.1097/00005792-200007000-00001. PMID 10941349.CS1 maint: Uses authors parameter (link)
  89. ↑ Sampson, E; Warner, JP (1999). "Serotonin syndrome: potentially fatal but difficult to recognize". Br J Gen Pract. 49 (448): 867–8. PMC 1313553. PMID 10818648.CS1 maint: Uses authors parameter (link)
  90. ↑ Rao, Sathyanarayana TS; Yeragani, VK (2009). "Hypertensive crisis and cheese". Indian J Psychiatry. 51 (1): 65–6. doi:10.4103/0019-5545.44910. PMC 2738414. PMID 19742203.CS1 maint: Uses authors parameter (link)
  91. ↑ Paykel, ES (1995). "Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression". Acta Psychiatr Scand Suppl. 386: 22–7. doi:10.1111/j.1600-0447.1995.tb05920.x. PMID 7717091.
  92. ↑ Malm, H (2012-12). "Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome". Therapeutic Drug Monitoring. 34 (6): 607–14. doi:10.1097/FTD.0b013e31826d07ea. PMID 23042258. Check date values in: |date= (help)
  93. ↑ Rahimi, R; Nikfar, S; Abdollahi, M (2006). "Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials". Reproductive Toxicology (Elmsford, N.Y.). 22 (4): 571–575. doi:10.1016/j.reprotox.2006.03.019. PMID 16720091.CS1 maint: Uses authors parameter (link)
  94. 1 2 Nikfar, S; Rahimi, R; Hendoiee, N; Abdollahi, M (2012). "Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis". Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 20 (1): 75. doi:10.1186/2008-2231-20-75. PMC 3556001. PMID 23351929.CS1 maint: Uses authors parameter (link)
  95. ↑ Huang, H; Coleman, S; Bridge, JA; Yonkers, K; Katon, W (2014). "A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight". General Hospital Psychiatry. 36 (1): 13–8. doi:10.1016/j.genhosppsych.2013.08.002. PMC 3877723. PMID 24094568.CS1 maint: Uses authors parameter (link)
  96. ↑ Einarson, TR; Kennedy, D; Einarson, A (2012). "Do findings differ across research design? The case of antidepressant use in pregnancy and malformations". Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Thérapeutique Des Populations Et De La Pharamcologie Clinique. 19 (2): e334–48. PMID 22946124.CS1 maint: Uses authors parameter (link)
  97. ↑ Riggin, L; Frankel, Z; Moretti, M; Pupco, A; Koren, G (2013-04). "The fetal safety of fluoxetine: a systematic review and meta-analysis". Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC. 35 (4): 362–9. PMID 23660045. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  98. ↑ Koren, G; Nordeng, HM (2013-02). "Selective serotonin reuptake inhibitors and malformations: case closed?". Seminars in Fetal & Neonatal Medicine. 18 (1): 19–22. doi:10.1016/j.siny.2012.10.004. PMID 23228547. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  99. ↑ "FDA Advising of Risk of Birth Defects with Paxil" (Press release). U.S. Food and Drug Administration. Archived from the original on 2013-12-03. สืบค้นเมื่อ 2012-11-29.
  100. ↑ Ross, Lori E.; Grigoriadis, Sophie; Mamisashvili, Lana; VonderPorten, Emily H.; Roerecke, Michael; Rehm, Jürgen; Dennis, Cindy-Lee; Koren, Gideon; Steiner, Meir; Mousmanis, Patricia; Cheung, Amy (2013-04-01). "Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant Medication". JAMA Psychiatry. 70 (4): 436. doi:10.1001/jamapsychiatry.2013.684.
  101. ↑ di Scalea, T Lanza; Wisner, KL (2009). "Antidepressant Medication Use During Breastfeeding". Clinical Obstetrics and Gynecology. 52 (3): 483–97. doi:10.1097/GRF.0b013e3181b52bd6. PMC 2902256. PMID 19661763.CS1 maint: Uses authors parameter (link)
  102. ↑ Sivagnanam, G (2012). "Antidepressants". Journal of Pharmacology and Pharmacotherapeutics. 3 (3): 287–8.
  103. ↑ Goldberg, JF; Truman, CJ (2003). "Antidepressant-induced mania: An overview of current controversies". Bipolar Disorders. 5 (6): 407–20. doi:10.1046/j.1399-5618.2003.00067.x. PMID 14636364.CS1 maint: Uses authors parameter (link)
  104. ↑ Benazzi, F (1997). "Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice". J Affect Disord. 46 (1): 73–7. doi:10.1016/S0165-0327(97)00082-7. PMID 9387089.
  105. 1 2 3 Stone, M; Laughren, T; Jones, ML; Levenson, M; Holland, PC; Hughes, A; Hammad, TA; Temple, R; Rochester, G (2009). "Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration". BMJ. 339: b2880. doi:10.1136/bmj.b2880. PMC 2725270. PMID 19671933.CS1 maint: Uses authors parameter (link)
  106. ↑ Friedman, RA; Leon, AC (2007). "Expanding the black box - depression, antidepressants, and the risk of suicide". N. Engl. J. Med. 356 (23): 2343–6. doi:10.1056/NEJMp078015. PMID 17485726.CS1 maint: Uses authors parameter (link)
  107. ↑ "Antidepressant Use in Children, Adolescents, and Adults". FDA.
  108. ↑ "FDA Medication Guide for Antidepressants" (PDF). สืบค้นเมื่อ 2014-06-05.
  109. ↑ update Cox, GR; Callahan, P; Churchill, R; Hunot, V; Merry, SN; Parker, AG; Hetrick, SE (2012). "Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents". Cochrane Database Syst Rev. 11: CD008324. doi:10.1002/14651858.CD008324.pub2. PMID 23152255.CS1 maint: Uses authors parameter (link)
  110. ↑ "Depression in adults: recognition and Depression in adults: recognition and management management (CG90)" (PDF). NICE. 2009-10-28. Archived from the original on 2015-11-03. สืบค้นเมื่อ 2016-09-01.
  111. ↑ Healy, D; Aldred, G (2005). "Antidepressant drug use and the risk of suicide" (PDF). International Review of Psychiatry. 17: 163–172. doi:10.1080/09540260500071624.CS1 maint: Uses authors parameter (link)
  112. ↑ Grant, Jon E.; Potenza, Marc N., eds. (2012). The Oxford handbook of impulse control disorders. Oxford: Oxford University Press. ISBN 978-0-19-538971-5.
  113. ↑ Csoka, AB; Csoka, A; Bahrick, A; Mehtonen, OP (2008). "Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors". J Sex Med. 5 (1): 227–33. doi:10.1111/j.1743-6109.2007.00630.x. PMID 18173768.CS1 maint: Uses authors parameter (link)
  114. ↑ Montejo, AL; Llorca, G; Izquierdo, JA; Rico-Villademoros, F (2001). "Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction". J Clin Psychiatry. 62 Suppl 3: 10–21. PMID 11229449.CS1 maint: Uses authors parameter (link)
  115. ↑ Serretti, A; Chiesa, A (2009). "Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis". J Clin Psychopharmacol. 29 (3): 259–66. doi:10.1097/JCP.0b013e3181a5233f. PMID 19440080.CS1 maint: Uses authors parameter (link)
  116. ↑ Chebili, S; Abaoub, A; Mezouane, B; JF, Le Goff (1998). "[Antidepressants and sexual stimulation: the correlation]". Encephale (in French). 24 (3): 180–4. PMID 9696909.CS1 maint: Uses authors parameter (link) CS1 maint: Unrecognized language (link)
  117. ↑ Keltner, NL; McAfee, KM; Taylor, CL (2009). "Biological Perspectives". Perspectives in Psychiatric Care. 38 (3): 111–6. doi:10.1111/j.1744-6163.2002.tb00665.x. PMID 12385082.CS1 maint: Uses authors parameter (link)
  118. ↑ Ozmenler, NK; Karlidere, T; Bozkurt, A; Yetkin, S; Doruk, A; Sutcigil, L; Cansever, A; Uzun, O; Ozgen, F; Ozsahin, A (2008). "Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors". Hum Psychopharmacol. 23 (4): 321–6. doi:10.1002/hup.929. PMID 18278806.CS1 maint: Uses authors parameter (link)
  119. ↑ Labbate, LA; Grimes, JB; Hines, A; Pollack, MH (1997-12). "Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction". Annals of Clinical Psychiatry. 9 (4): 241–5. doi:10.3109/10401239709147804. PMID 9511948. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  120. ↑ Stimmel, GL; Dopheide, JA; Stahl, SM (1997). "Mirtazapine: An antidepressant with noradrenergic and specific serotonergic effects". Pharmacotherapy. 17 (1): 10–21. doi:10.1002/j.1875-9114.1997.tb03674.x. PMID 9017762.CS1 maint: Uses authors parameter (link)
  121. ↑ "mirtazapine (Rx) - Remeron, Remeron SolTab". Medscape. WebMD. Archived from the original on 2013-10-29. สืบค้นเมื่อ 2013-11-19.
  122. ↑ Papakostas, GI (2008). "Tolerability of modern antidepressants". J Clin Psychiatry. 69 (Suppl E1): 8–13. PMID 18494538.
  123. ↑ Li, Z; Maglione, M; Tu, W; Mojica, W; Arterburn, D; Shugarman, LR; Hilton, L; Suttorp, M; Solomon, V; Shekelle, PG; Morton, SC (2005-04). "Meta-analysis: pharmacologic treatment of obesity". Ann. Intern. Med. 142 (7): 532–46. doi:10.7326/0003-4819-142-7-200504050-00012. PMID 15809465. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  124. ↑ "Effexor Medicines Data Sheet". Wyeth Pharmaceuticals Inc. 2006. Archived from the original on 2006-09-17. สืบค้นเมื่อ 2006-09-17.
  125. 1 2 3 Haddad, P. (2001). "Antidepressant discontinuation syndromes". Drug Saf. 24 (3): 183–97. doi:10.2165/00002018-200124030-00003. PMID 11347722.
  126. 1 2 3 4 Warner, CH; Bobo, W; Warner, C; Reid, S; Rachal, J (2006-08). "Antidepressant discontinuation syndrome". Am Fam Physician. 74 (3): 449–56. PMID 16913164. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  127. ↑ Haddad, P.M.; Anderson, I.M. (2007). "Recognising and managing antidepressant discontinuation symptoms". Advances in Psychiatric Treatment. 13 (6): 447–457. doi:10.1192/apt.bp.105.001966.
  128. ↑ Renoir, T (2013-04). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved". Front Pharmacol. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418. Check date values in: |date= (help)
  129. ↑ Haddad, PM; Dursun, SM (2008-01). "Neurological complications of psychiatric drugs: clinical features and management". Hum Psychopharmacol. 23 (Suppl 1): 15–26. doi:10.1002/hup.918. PMID 18098217. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  130. ↑ Tamam, L.; Ozpoyraz, N. (2002, January-February). "Selective Serotonin Reuptake Inhibitor Discontinuation Syndrome: A Review". Advances in Therapy. 19 (1): 17–26. doi:10.1007/BF02850015. PMID 12008858. สืบค้นเมื่อ 2012-11-28. Check date values in: |date= (help)
  131. ↑ Gartlehner, G; Hansen, RA; Morgan, LC และคณะ (2011-12). Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review. Rockville, MD, USA: Agency for Healthcare Research and Quality. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link) CS1 maint: Explicit use of et al. (link)
  132. ↑ Stutz, Bruce (2007-05-06). "Self-Nonmedication". New York Times. สืบค้นเมื่อ 2010-05-24.
  133. ↑ Shelton, RC (2006). "The nature of the discontinuation syndrome associated with antidepressant drugs". J Clin Psychiatry. 67 (Suppl 4): 3–7. PMID 16683856.
  134. ↑ WHO Expert Committee on Drug Dependence (2003). "WHO Technical Report Series, No. 915 - Thirty-third Report". WHO.CS1 maint: Uses authors parameter (link)
  135. ↑ Evans, EA; Sullivan, MA (2014-08). "Abuse and misuse of antidepressants". Subst Abuse Rehabil. 5: 107–20. doi:10.2147/SAR.S37917. PMID 25187753. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  136. ↑ Nielsen, M; al., et (2012-05). "What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors". Addiction. 107 (5): 900–8. doi:10.1111/j.1360-0443.2011.03686.x. PMID 21992148. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  137. ↑ Brady, K (2012-05). "Withdrawal or dependence: a matter of context. Comment on: What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors". Addiction. 107 (5): 910–1. doi:10.1111/j.1360-0443.2012.03862.x. PMID 22471576. Check date values in: |date= (help)
  138. ↑ Lader, M (2012-05). "Dependence and withdrawal: comparison of the benzodiazepines and selective serotonin re-uptake inhibitors. Comment on: What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors". Addiction. 107 (5): 909–10. doi:10.1111/j.1360-0443.2011.03736.x. PMID 22471575. Check date values in: |date= (help)
  139. 1 2 Maes, M; Yirmyia, R; Noraberg, J; Brene, S; Hibbeln, J; Perini, G; Kubera, M; Bob, P; Lerer, B; Maj, M (2009-03). "The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression". Metabolic Brain Disease. 24 (1): 27–53. doi:10.1007/s11011-008-9118-1. PMID 19085093. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  140. 1 2 Sanacora, G; Treccani, G; Popoli, M (2012-01). "Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders". Neuropharmacology. 62 (1): 63–77. doi:10.1016/j.neuropharm.2011.07.036. PMC 3205453. PMID 21827775. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  141. ↑ Menke, A; Klengel, T; Binder, EB (2012). "Epigenetics, depression and antidepressant treatment". Current Pharmaceutical Design. 18 (36): 5879–5889. doi:10.2174/138161212803523590. PMID 22681167.CS1 maint: Uses authors parameter (link)
  142. ↑ Vialou, V; Feng, J; Robison, AJ; Nestler, EJ (2013-01). "Epigenetic mechanisms of depression and antidepressant action". Annual Review of Pharmacology and Toxicology. 53 (1): 59–87. doi:10.1146/annurev-pharmtox-010611-134540. PMID 23020296. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  143. ↑ Preskorn, SH; Ross, R; Stanga, CY (2004). "Selective Serotonin Reuptake Inhibitors". In Sheldon H. Preskorn; Hohn P. Feighner; Christina Y. Stanga; Ruth Ross. Antidepressants: Past, Present and Future. Berlin: Springer. pp. 241–62. ISBN 978-3-540-43054-4.CS1 maint: Uses authors parameter (link)
  144. ↑ Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J (2010-01). "Antidepressant Drug Effects and Depression Severity". JAMA: The Journal of the American Medical Association. 303 (1): 47–53. doi:10.1001/jama.2009.1943. PMC 3712503. PMID 20051569. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  145. ↑ Kramer, Peter (2011-09-07). "In Defense of Antidepressants". The New York Times. สืบค้นเมื่อ 2011-07-13.
  146. ↑ Pies, R (2010-04). "Antidepressants Work, Sort of-Our System of Care Does Not". Journal of Clinical Psychopharmacology. 30 (2): 101–104. doi:10.1097/JCP.0b013e3181d52dea. PMID 20520282. Check date values in: |date= (help)
  147. ↑ Cashman, JR; Ghirmai, S (2009). "Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression". Bioorganic & Medicinal Chemistry. 17 (19): 6890–7. doi:10.1016/j.bmc.2009.08.025. PMID 19740668.
  148. ↑ Goldenberg, MM (2013-11). "Pharmaceutical approval update". P T. 38 (11): 705–7. PMC 3875258. PMID 24391391. Check date values in: |date= (help)
  149. ↑ "Vortioxetine: Atypical antidepressant". American Pharmacists Association. 2013.
  150. ↑ "FDA approves a new antidepressant: Brintellix". Los Angeles Times. 2013.
  151. ↑ Hughes, ZA; Starr, KR; Langmead, CJ และคณะ (2005-03). "Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone". European Journal of Pharmacology. 510 (1–2): 49–57. doi:10.1016/j.ejphar.2005.01.018. PMID 15740724. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link) CS1 maint: Explicit use of et al. (link)
  152. ↑ Muntner, Stephen M. (2013). Stahl's essential psychopharmacology : neuroscientific basis and practical application. illustrations by Nancy Stahl (4th ed.). Cambridge: Cambridge University Press. ISBN 978-1107686465.
  153. ↑ Wee, S; Woolverton, WL (2004-09). "Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine". Drug and Alcohol Dependence. 75 (3): 271–6. doi:10.1016/j.drugalcdep.2004.03.010. PMID 15283948. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  154. ↑ Gasior, M; Bergman, J; Kallman, MJ; Paronis, CA (2005-04). "Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys". Neuropsychopharmacology. 30 (4): 758–64. doi:10.1038/sj.npp.1300593. PMID 15526000. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  155. ↑ Rothman, RB; Baumann, MH; Dersch, CM และคณะ (2001-01). "Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin". Synapse. 39 (1): 32–41. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3. PMID 11071707. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link) CS1 maint: Explicit use of et al. (link)
  156. 1 2 Tatsumi, M; Groshan, K; Blakely, RD; Richelson, E (1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". Eur J Pharmacol. 340 (2–3): 249–258. doi:10.1016/S0014-2999(97)01393-9. PMID 9537821.CS1 maint: Uses authors parameter (link)
  157. ↑ Gillman, PK (2007-07). "Tricyclic antidepressant pharmacology and therapeutic drug interactions updated". British Journal of Pharmacology. 151 (6): 737–48. doi:10.1038/sj.bjp.0707253. PMC 2014120. PMID 17471183. Check date values in: |date= (help)
  158. ↑ Rénéric, JP; Lucki, I (1998-03). "Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test". Psychopharmacology. 136 (2): 190–7. doi:10.1007/s002130050555. PMID 9551776. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  159. ↑ Trindade, E; Menon, D; Topfer, LA; Coloma, C (1998). "Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis". Canadian Medical Association Journal. 159 (10): 1245–1252.CS1 maint: Uses authors parameter (link)
  160. ↑ Cristancho, Mario. "Atypical Depression in the 21st Century: Diagnostic and Treatment Issues". Psychiatric Times. สืบค้นเมื่อ 2013-11-23.
  161. ↑ "Depression (major depression) : Treatment and drugs". Mayo Clinic.
  162. ↑ Buigues, J; Vallejo, J (1987). "Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks". Journal of Clinical Psychiatry. 48 (2): 55–9.
  163. ↑ Liebowitz, MR; Schneier, FR; Campeas, R; Hollander, E; Hatterer, J; Fyer, A; และคณะ (1992). "Phenelzine vs atenolol in social phobia: A placebo-controlled comparison". Archives of General Psychiatry. 49 (4): 290–300.
  164. ↑ Versiani, M; Nardi, AE; Mundim, FD; Alves, AB; Liebowitz, MR; Amrein, R (1992-09-01). "Pharmacotherapy of social phobia: A controlled study with moclobemide and phenelzine". BJP [Internet]. 161 (3): 353–60.CS1 maint: Uses authors parameter (link)
  165. ↑ Heimberg, RG; Liebowitz, MR; Hope, DA; และคณะ. "Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome". Arch Gen Psychiatry. 55 (12): 1133–41. doi:10.1001/archpsyc.55.12.1133.
  166. ↑ Jarrett, RB; Schaffer, M; McIntire, D; Witt-Browder, A; Kraft, D; Risser, RC. "Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial". Arch Gen Psychiatry. 56 (5): 431–7. doi:10.1001/archpsyc.56.5.431.
  167. ↑ Liebowitz, MR; Quitkin, FM; Stewart, JW; และคณะ. "Phenelzine v imipramine in atypical depression: A preliminary report". Arch Gen Psychiatry. 41 (7): 669–77. doi:10.1001/archpsyc.1984.01790180039005.
  168. ↑ Walsh, B; Stewart, JW; Roose, SP; Gladis, M; Glassman, AH. "Treatment of bulimia with phenelzine: A double-blind, placebo-controlled study". Arch Gen Psychiatry. 41 (11): 1105–9. doi:10.1001/archpsyc.1983.01790220095015.
  169. ↑ Rothschild, R; Quitkin, HM; Quitkin, FM; Stewart, JW; Ocepek-Welikson, K; McGrath, PJ และคณะ. "A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives". International Journal of Eating Disorders. 15 (1): 1–9. doi:10.1002/1098-108X(199401)15:1<1::AID-EAT2260150102>3.0.CO;2-E.CS1 maint: Uses authors parameter (link)
  170. ↑ Walsh, BT; Stewart, JW; Roose, SP; Gladis, M; Glassman, AH. "A double-blind trial of phenelzine in bulimia". Journal of Psychiatric Research. 19 (2–3): 485–9. doi:10.1016/0022-3956(85)90058-5.
  171. ↑ Walsh, B; Gladis, M; Roose, SP; Stewart, JW; Stetner, F; Glassman, AH (1988-05). "Phenelzine vs placebo in 50 patients with bulimia". Arch Gen Psychiatry. 45 (5): 471–5. doi:10.1001/archpsyc.1988.01800290091011. PMID 3282482. Check date values in: |date= (help)
  172. ↑ Davidson, J; Ingram, J; Kilts, C (1987). "A pilot study of phenelzine in the treatment of post-traumatic stress disorder". The British Journal of Psychiatry. 150: 252–5. doi:10.1192/bjp.150.2.252.
  173. ↑ Soloff, PH; Cornelius, J; George, A; Nathan, S; Perel, JM; Ulrich, RF. "Efficacy of phenelzine and haloperidol in borderline personality disorder". Arch Gen Psychiatry. 50 (5): 377–85. doi:10.1001/archpsyc.1993.01820170055007.
  174. ↑ Mallinger, AG; Frank, E; Thase, ME; Barwell, MM; DiazGranados, N; Luckenbaugh, DA; และคณะ (2009). "Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?". Psychopharmacol Bull. 42 (2): 64–74.
  175. ↑ Liebowitz, MR; Hollander, E; Schneier, F; Campeas, R; Welkowitz, L; Hatterer, J; Fallon, B (1990). "Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders". Acta Psychiatr Scand Suppl. 360: 29–34. doi:10.1111/j.1600-0447.1990.tb05321.x. PMID 2248064.
  176. ↑ "Depressive Disorders". Merck Manual. Archived from the original on 2013-12-05. สืบค้นเมื่อ 2012-11-30.
  177. ↑ Taylor, D; Carol, P; Shitij, K (2012). The Maudsley prescribing guidelines in psychiatry. West Sussex: Wiley-Blackwell. ISBN 978-0-470-97969-3.
  178. ↑ Bauer, M; Dopfmer, S (1999). "Lithium augmentation in treatment-resistant depression: Meta-analysis of placebo-controlled studies". Journal of Clinical Psychopharmacology. 19 (5): 427–34. doi:10.1097/00004714-199910000-00006. PMID 10505584.CS1 maint: Uses authors parameter (link)
  179. ↑ Guzzetta, F; Tondo, L; Centorrino, F; Baldessarini, RJ (2007-03). "Lithium treatment reduces suicide risk in recurrent major depressive disorder". J Clin Psychiatry. 68 (3): 380–83. doi:10.4088/JCP.v68n0304. PMID 17388706. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  180. ↑ Nierenberg, AA; Fava, M; Trivedi, MH; Wisniewski, SR; Thase, ME; McGrath, PJ; Alpert, JE; Warden, D; Luther, JF; Niederehe, G; Lebowitz, B; Shores-Wilson, K; Rush, AJ (2006). "A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: A STAR*D report". American Journal of Psychiatry. 163 (9): 1519–30. doi:10.1176/appi.ajp.163.9.1519. PMID 16946176.CS1 maint: Uses authors parameter (link)
  181. ↑ Stahl, Stephen M. (2011). The Prescriber's Guide (Stahl's Essential Psychopharmacology). Cambridge University Press. p. 39. classical augmentation strategy for treatment-refractory depression
  182. ↑ Kraus, MF; Burch, EA (1992). "Methylphenidate hydrochloride as an antidepressant: controversy, case studies, and review". South. Med. J. 85 (10): 985–91. doi:10.1097/00007611-199210000-00012. PMID 1411740.CS1 maint: Uses authors parameter (link)
  183. 1 2 Orr, K; Taylor, D (2007). "Psychostimulants in the treatment of depression : a review of the evidence". CNS Drugs. 21 (3): 239–57. doi:10.2165/00023210-200721030-00004. PMID 17338594.
  184. 1 2 Weber, MM; Emrich, HM (1988). "Current and Historical Concepts of Opiate Treatment in Psychiatric Disorders". International Clinical Psychopharmacology. 3 (3): 255–66. doi:10.1097/00004850-198807000-00007. PMID 3153713.CS1 maint: Uses authors parameter (link)
  185. ↑ Heal, DJ; Smith, SL; Gosden, J; Nutt, DJ (2013-06). "Amphetamine, past and present - a pharmacological and clinical perspective". J. Psychopharmacol. 27 (6): 479–96. doi:10.1177/0269881113482532. PMC 3666194. PMID 23539642. Check date values in: |date= (help)CS1 maint: Uses authors parameter (link)
  186. ↑ Czygan, FC (2003). "Kulturgeschichte und Mystik des Johanniskrauts: Vom 2500 Jahre alten Apotropaikum zum aktuellen Antidepressivum". Pharmazie in unserer Zeit (in German). 32 (3): 184–90. doi:10.1002/pauz.200390062. PMID 12784538. Unknown parameter |trans_title= ignored (help)CS1 maint: Unrecognized language (link)
  187. ↑ Selikoff, IJ; Robitzek, EH (1952). "Tuberculosis Chemotherapy with Hydrazine Derivatives of Isonicotinic Acid". CHEST Journal. 21 (4): 385–438. doi:10.1378/chest.21.4.385. PMID 14906149.CS1 maint: Uses authors parameter (link)
  188. ↑ Healy, D (2001). "The Antidepressant Drama". In Weissman, M.M. The treatment of depression: bridging the 21st century. American Psychiatric Pub. pp. 10–11. ISBN 978-0-88048-397-1. สืบค้นเมื่อ 2009-05-28.
  189. ↑ Healy, David (1996). The psychopharmacologists: interviews. London: Chapman and Hall. p. 8. ISBN 978-1-86036-008-4.
  190. ↑ Healy, David (1998). The Psychopharmacologists: Volume 2. A Hodder Arnold Publication. pp. 132–4. ISBN 978-1-86036-010-7.
  191. ↑ Robitzek, EH; Selikoff, IJ; Mamlok, E; Tendlau, A (1953). "Isoniazid and Its Isopropyl Derivative in the Therapy of Tuberculosis in Humans: Comparative Therapeutic and Toxicologic Properties". CHEST Journal. 23 (1): 1–15. doi:10.1378/chest.23.1.1. PMID 12998444.CS1 maint: Uses authors parameter (link)
  192. 1 2 3 4 López-Muñoz, F; Alamo, C; Juckel, G; Assion, HJ (2007). "Half a Century of Antidepressant Drugs". Journal of Clinical Psychopharmacology. 27 (6): 555–9. doi:10.1097/jcp.0b013e3181bb617. PMID 18004120.CS1 maint: Uses authors parameter (link)
  193. ↑ "Psychic Energizer". Time. 1957-04-15. Archived from the original on 2013-08-11. สืบค้นเมื่อ 2009-05-28.
  194. ↑ Kuhn, R (1958). "The treatment of depressive states with G 22355 (imipramine hydrochloride)". The American Journal of Psychiatry. 115 (5): 459–64. PMID 13583250.
  195. ↑ "Tranquilizers". Cumberland Mountain Community Services. www.cmcsb.com. Archived from the original on 2012-09-16. สืบค้นเมื่อ 2013-11-20.[แหล่งอ้างอิงทางการแพทย์ที่ไม่น่าเชื่อถือ?]
  196. 1 2 Healy, D (1999). "The Three Faces of the Antidepressants: A Critical Commentary on the Clinical-Economic Context of Diagnosis". The Journal of Nervous & Mental Disease. 187 (3): 174–80. doi:10.1097/00005053-199903000-00007. PMID 10086474.
  197. ↑ Pletscher, A (1991). "The discovery of antidepressants: A winding path". Experientia. 47 (1): 4–8. doi:10.1007/BF02041242. PMID 1999242.
  198. ↑ Domino, EF (1999). "History of modern psychopharmacology: A personal view with an emphasis on antidepressants". Psychosomatic Medicine. 61 (5): 591–8. doi:10.1097/00006842-199909000-00002. PMID 10511010.
  199. ↑ Wong, DT; Bymaster, FP; Horng, JS; Molloy, BB (1975). "A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3- (p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine". The Journal of Pharmacology and Experimental Therapeutics. 193 (3): 804–11. PMID 1151730.CS1 maint: Uses authors parameter (link)
  200. ↑ Freeman, H (1996). "Tolerability and safety of novel antidepressants". European Psychiatry. 11: 206s. doi:10.1016/0924-9338(96)88597-X.
  201. ↑ Linde, K; Ramirez, G; Mulrow, CD; Pauls, A; Weidenhammer, W; Melchart, D (1996). "St John's wort for depression—an overview and meta-analysis of randomised clinical trials". BMJ. 313 (7052): 253–8. doi:10.1136/bmj.313.7052.253. PMC 2351679. PMID 8704532.CS1 maint: Uses authors parameter (link)
  202. ↑ Müller, WE (2003). "Current St. John's wort research from mode of action to clinical efficacy". Pharmacological Research. 47 (2): 101–9. doi:10.1016/S1043-6618(02)00266-9. PMID 12543057.
  203. ↑ Nathan, PJ (2001). "Hypericum perforatum (St John's Wort) : A non-selective reuptake inhibitor? A review of the recent advances in its pharmacology". Journal of Psychopharmacology. 15 (1): 47–54. doi:10.1177/026988110101500109. PMID 11277608.
  204. 1 2 White, Rebecca. "Waking up from sadness: Many find trouble getting off antidepressants". Al Jazeera. สืบค้นเมื่อ 2014-06-08.
  205. ↑ Davis, Rowenna (2010-06-11). "Antidepressant Use Rises as Recession Feeds Wave of Worry". The Guardian. London. Archived from the original on 2010-06-15. สืบค้นเมื่อ 2010-07-01.
  206. ↑ Spence, Ruth. "Focus on: Antidepressant prescribing". QualityWatch. QualityWatch (Nuffield Trust/Health Foundation). สืบค้นเมื่อ 2015-01-12.
  207. ↑ "Top 200 generic drugs by units in 2010" (PDF). Archived from the original (PDF) on 2012-12-015. Check date values in: |archivedate= (help)
  208. ↑ "Top 200 brand drugs by units in 2010" (PDF). Archived from the original (PDF) on 2012-04-22.
  209. ↑ "GIPdatabank". Gipdatabank.nl. สืบค้นเมื่อ 2008-11-06.
  210. 1 2 3 Ecks, S (2005). "Pharmaceutical Citizenship: Antidepressant Marketing and the Promise of Demarginalization in India". Anthropology & Medicine. 12 (3): 239–254. doi:10.1080/13648470500291360.
  211. 1 2 Lock, M; Nguyen, VK (2010). ""Local Biologies and Human Difference". An anthropology of biomedicine (1st ed.). Chichester, West Sussex: Wiley-Blackwell. pp. 83–109. ISBN 1-4051-1071-6.CS1 maint: Uses authors parameter (link)
  212. ↑ "Pharmacokinetics of selective serotonin reuptake inhibitors" (PDF). Archived from the original (PDF) on 2014-05-23.
  213. ↑ Nentwig, G (2007). "Effects of pharmaceuticals on aquatic invertebrates. Part II: the antidepressant drug fluoxetine". Arch. Environ. Contam. Toxicol. 52 (2): 163–70. doi:10.1007/s00244-005-7190-7. PMID 17160491.
  214. ↑ Zhou, Z; Zhen, J; Karpowich, NK; Goetz, RM; Law, CJ; Reith, ME; Wang, DN (2007). "LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake". Science. 317 (5843): 1390–3. doi:10.1126/science.1147614. PMC 3711652. PMID 17690258.CS1 maint: Uses authors parameter (link)
  215. ↑ Fong, PP (2001). "Antidepressants in Aquatic Organisms: A Wide Range of Effects". In Daughton, CG; Jones-Lepp, TJ. Pharmaceuticals and personal care products in the environment: scientific and regulatory issues. Washington, DC: American Chemical Society. pp. 264–281. ISBN 978-0-8412-3739-1.CS1 maint: Uses editors parameter (link)
  216. ↑ Brooks, BW; Chambliss, CK; Stanley, JK; Ramirez, A; Banks, KE; Johnson, RD; Lewis, RJ (2005). "Determination of select antidepressants in fish from an effluent-dominated stream". Environ. Toxicol. Chem. 24 (2): 464–9. doi:10.1897/04-081r.1. PMID 15720009.CS1 maint: Uses authors parameter (link)
  217. ↑ Fent, K; Weston, AA; Caminada, D (2006). "Ecotoxicology of human pharmaceuticals". Aquat. Toxicol. 76 (2): 122–59. doi:10.1016/j.aquatox.2005.09.009. PMID 16257063.CS1 maint: Uses authors parameter (link)
  218. ↑ Winberg, S; Carter, CG; McCarthy, JD; He, XY; Nilsson, GE; Houlihan, DF (1993). Feeding rank and brain serotonergic activity in rainbow trout Onchorhynchus my kiss. J. Exp. Biol. 179. pp. 197–211.CS1 maint: Uses authors parameter (link)
  219. ↑ Perreault, HA; Semsar, K; Godwin, J (2003). "Fluoxetine treatment decreases territorial aggression in a coral reef fish". Physiol. Behav. 79 (4–5): 719–24. doi:10.1016/S0031-9384(03)00211-7. PMID 12954414.CS1 maint: Uses authors parameter (link)
  220. ↑ Huber, R; Smith, K; Delago, A; Isaksson, K; Kravitz, EA (1997). "Serotonin and aggressive motivation in crustaceans: altering the decision to retreat". Proc. Natl. Acad. Sci. U.S.A. 94 (11): 5939–42. doi:10.1073/pnas.94.11.5939. PMC 20885. PMID 9159179.CS1 maint: Uses authors parameter (link)
  221. ↑ Di Poi, C; Darmaillacq, AS; Dickel, L; Boulouard, M; Bellanger, C (2013). "Effects of perinatal exposure to waterborne fluoxetine on memory processing in the cuttlefish Sepia officinalis". Aquat. Toxicol. 132-133: 84–91. doi:10.1016/j.aquatox.2013.02.004. PMID 23474317.CS1 maint: Uses authors parameter (link)

แหล่งที่มา

WikiPedia: ยาแก้ซึมเศร้า http://america.aljazeera.com/articles/2014/1/22/pa... http://www.cmcsb.com/tranquil.htm http://linkinghub.elsevier.com/retrieve/pii/S0014-... http://linkinghub.elsevier.com/retrieve/pii/S03768... http://www.jpharmacol.com/text.asp?2012/3/3/287/99... http://www.latimes.com/science/sciencenow/la-sci-f... http://www.mayoclinic.com/health/depression/DS0017... http://reference.medscape.com/drug/remeron-soltab-... http://www.medscape.com/viewarticle/570825+ http://www.merckmanuals.com/professional/psychiatr...